152.15 USD
+0.47
0.31%
At close Apr 17, 4:00 PM EDT
After hours
152.15
+0.00
0.00%
1 day
0.31%
5 days
-1.54%
1 month
-11.94%
3 months
-11.69%
6 months
6.44%
Year to date
-9.74%
1 year
11.37%
5 years
-23.81%
10 years
345.66%
 

About: Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

Employees: 3,600

0
Funds holding %
of 7,407 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

70% more call options, than puts

Call options by funds: $21.3M | Put options by funds: $12.6M

33% more funds holding in top 10

Funds holding in top 10: 3 [Q3] → 4 (+1) [Q4]

27% more capital invested

Capital invested by funds: $6.68B [Q3] → $8.49B (+$1.81B) [Q4]

22% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 50

2.3% more ownership

Funds ownership: 94.31% [Q3] → 96.6% (+2.3%) [Q4]

1% more funds holding

Funds holding: 356 [Q3] → 358 (+2) [Q4]

0% more repeat investments, than reductions

Existing positions increased: 115 | Existing positions reduced: 115

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$205
35%
upside
Avg. target
$210
38%
upside
High target
$215
41%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
Piper Sandler
Jason Bednar
17% 1-year accuracy
6 / 35 met price target
41%upside
$215
Overweight
Maintained
26 Feb 2025
Wells Fargo
Vik Chopra
36% 1-year accuracy
4 / 11 met price target
35%upside
$205
Overweight
Maintained
26 Feb 2025

Financial journalist opinion

Based on 7 articles about MASI published over the past 30 days

Positive
Zacks Investment Research
21 hours ago
Why Masimo (MASI) Could Beat Earnings Estimates Again
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Masimo (MASI) Could Beat Earnings Estimates Again
Positive
Zacks Investment Research
1 day ago
Why You Shouldn't Bet Against Masimo (MASI) Stock
Masimo (MASI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Why You Shouldn't Bet Against Masimo (MASI) Stock
Positive
Zacks Investment Research
1 week ago
Here's Why Masimo (MASI) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Masimo (MASI) is a Strong Growth Stock
Neutral
Zacks Investment Research
2 weeks ago
3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes
In 2025, companies like MASI, BSX and HIMS are expected to overcome challenges and sustain strong growth and market leadership.
3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes
Positive
Zacks Investment Research
2 weeks ago
Masimo (MASI) is an Incredible Growth Stock: 3 Reasons Why
Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Masimo (MASI) is an Incredible Growth Stock: 3 Reasons Why
Neutral
Business Wire
2 weeks ago
Masimo to Present in the 24th Annual Needham Virtual Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025 at 2:15 p.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide ar.
Masimo to Present in the 24th Annual Needham Virtual Healthcare Conference
Positive
Zacks Investment Research
4 weeks ago
Why Masimo (MASI) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Masimo (MASI) is a Top Growth Stock for the Long-Term
Positive
Zacks Investment Research
1 month ago
3 Reasons Growth Investors Will Love Masimo (MASI)
Masimo (MASI) could produce exceptional returns because of its solid growth attributes.
3 Reasons Growth Investors Will Love Masimo (MASI)
Neutral
Zacks Investment Research
1 month ago
Buy 3 Momentum Anomaly Stocks as Tariffs Take a Toll on Markets
MASI, HOOD and DFS are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
Buy 3 Momentum Anomaly Stocks as Tariffs Take a Toll on Markets
Positive
Zacks Investment Research
1 month ago
Masimo Corporation (MASI) Hit a 52 Week High, Can the Run Continue?
Masimo (MASI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Masimo Corporation (MASI) Hit a 52 Week High, Can the Run Continue?
Charts implemented using Lightweight Charts™